TRM82 Antibody

What is TRM82 and what biological functions does it serve?

TRM82 (also known as TRMT82) functions as the non-catalytic subunit of the tRNA (guanine-N(7)-)-methyltransferase complex. It works in conjunction with TRM8 to form a complex that catalyzes the 7-methylguanosine (m7G) modification of specific tRNAs . This complex plays a crucial role in enhancing translational fidelity through structural stabilization of tRNAs, essentially maintaining proper protein synthesis accuracy . In yeast, where much of the fundamental research has been conducted, TRM82 is also known as a transfer RNA methyltransferase that contributes to the regulation of central carbon metabolism and amino acid biosynthesis pathways .

What is the relationship between TRM82 and WDR4?

WDR4 (WD Repeat-containing Protein 4) is the human ortholog of yeast TRM82 . Both proteins serve as non-catalytic subunits of tRNA methyltransferase complexes. WDR4/TRM82 contains WD-repeat domains that likely facilitate protein-protein interactions within the methyltransferase complex . While the nomenclature differs between species, the functional role in tRNA modification is conserved, making antibodies against either protein valuable for comparative studies across model organisms.

What types of TRM82/WDR4 antibodies are currently available for research applications?

Several types of antibodies targeting TRM82/WDR4 are available for research purposes:

Most commercially available antibodies are applicable for Western Blot analysis, with some also validated for immunohistochemistry, immunoprecipitation, and ELISA applications .

How should researchers select the appropriate TRM82 antibody for their experimental system?

When selecting a TRM82 antibody, consider:

• Target organism specificity: Ensure the antibody has been validated for your species of interest (human, mouse, rat, or yeast) .

• Application compatibility: Verify the antibody has been tested for your intended application (WB, IHC, IP, ELISA) .

• Epitope location: For functional studies, select antibodies targeting functionally relevant domains.

• Clonality: Polyclonal antibodies offer broader epitope recognition but potentially higher background, while monoclonal antibodies provide higher specificity.

• Validation data: Review published literature using the specific antibody to confirm its performance in contexts similar to your experimental design.

How does the Trm8/Trm82 complex influence cellular metabolism?

Recent research has demonstrated that the Trm8/Trm82 complex exerts significant influence on cellular metabolism, particularly in yeast systems. Overexpression of this complex upregulates genes involved in amino acid synthesis, glycolysis, and the tricarboxylic acid (TCA) cycle . Transcriptomic analysis revealed that Trm8/Trm82 overexpression resulted in the differential expression of numerous genes associated with metabolic processes, particularly organic acid metabolism, carboxylic acid metabolism, and oxoacid metabolism .

KEGG pathway enrichment analysis showed that differentially expressed genes were primarily enriched in pathways related to:

• Amino acid biosynthesis

• Secondary metabolite biosynthesis

• Carbon metabolism

• 2-oxocarboxylic acid metabolism

• Tricarboxylic acid cycle

• Glycolysis/gluconeogenesis

These findings suggest that the tRNA m7G modification catalyzed by the Trm8/Trm82 complex has broader implications beyond translation fidelity, extending to metabolic regulation.

What role does TRM82 play in terpenoid biosynthesis?

Overexpression of the Trm8/Trm82 complex in yeast has been found to promote squalene biosynthesis . Squalene is a key intermediate in the terpenoid biosynthesis pathway, which originates from acetyl-CoA through the mevalonate (MVA) pathway. The Trm8/Trm82 complex appears to enhance terpenoid biosynthesis by upregulating genes involved in the upstream pathway of acetyl-CoA synthesis .

The mechanism involves the upregulation of central carbon metabolism pathways, particularly glycolysis, which increases the flux toward acetyl-CoA production. This, in turn, provides more precursors for the MVA pathway, leading to enhanced production of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), the building blocks for all terpenoids .

What experimental approaches are most effective for studying TRM82 function in tRNA modification?

For studying TRM82's role in tRNA modification, researchers should consider:

• Genetic manipulation approaches:

  • Gene knockout/knockdown to assess loss-of-function effects

  • Overexpression studies to evaluate gain-of-function effects

  • Site-directed mutagenesis to analyze specific functional domains

• Biochemical characterization:

  • Immunoprecipitation to identify interaction partners

  • Mass spectrometry to detect m7G-modified tRNAs

  • In vitro methyltransferase assays with purified components

• Transcriptomic and proteomic analyses:

  • RNA-Seq to assess global effects on gene expression

  • Ribosome profiling to examine translation efficiency

  • Proteomics to evaluate protein abundance changes

• Metabolic studies:

  • Gas chromatography-mass spectrometry (GC-MS) to detect metabolic changes

  • Isotope labeling to track carbon flux through central metabolism

  • mRNA stability assays to assess post-transcriptional regulation

What are the optimal conditions for Western blot analysis using TRM82 antibodies?

For optimal Western blot results with TRM82 antibodies:

• Sample preparation:

  • Use fresh tissue/cell lysates when possible

  • Include protease inhibitors to prevent degradation

  • Denature samples at 95°C for 5 minutes in reducing buffer

• Gel electrophoresis parameters:

  • Use 10-12% SDS-PAGE gels for optimal separation

  • Load 20-40 μg of total protein per lane

  • Include molecular weight markers spanning 40-100 kDa range (TRM82/WDR4 is approximately 50-55 kDa)

• Transfer conditions:

  • Use PVDF membrane for better protein retention

  • Transfer at 100V for 1 hour or 30V overnight at 4°C

  • Verify transfer efficiency with reversible protein stain

• Antibody incubation:

  • Block with 5% non-fat milk or BSA for 1 hour at room temperature

  • Use primary antibody at 1:500-1:1000 dilution overnight at 4°C

  • Wash 3×10 minutes with TBST

  • Incubate with HRP-conjugated secondary antibody at 1:2000-1:5000 for 1 hour at room temperature

• Detection:

  • Use enhanced chemiluminescence (ECL) reagents

  • Optimize exposure time to avoid saturation

  • Include positive control lysates from cells known to express TRM82/WDR4

How can researchers validate the specificity of TRM82 antibodies?

To ensure antibody specificity:

• Positive and negative controls:

  • Include lysates from cells/tissues known to express TRM82/WDR4

  • Use knockout/knockdown samples as negative controls

  • Compare multiple antibodies targeting different epitopes

• Peptide competition assay:

  • Pre-incubate antibody with excess immunizing peptide

  • Run parallel Western blots with blocked and unblocked antibody

  • Specific bands should disappear in the blocked condition

• Cross-reactivity assessment:

  • Test antibody against recombinant TRM82/WDR4 protein

  • Evaluate specificity across species if conducting comparative studies

  • Examine potential cross-reactivity with structurally similar proteins

• Immunoprecipitation followed by mass spectrometry:

  • Confirm that immunoprecipitated proteins include TRM82/WDR4

  • Identify potential cross-reactive proteins

  • Validate interaction partners

What methodological approaches are recommended for studying the Trm8/Trm82 complex in different model systems?

For studying the Trm8/Trm82 complex across model systems:

• Yeast models (S. cerevisiae):

  • Gene deletion/overexpression is straightforward using homologous recombination

  • Use GAL1 promoter for inducible expression studies

  • Monitor phenotypes including growth rate, tRNA modification levels, and metabolite production

  • Apply transcriptome analysis to identify regulatory networks

• Mammalian cell culture:

  • Use CRISPR/Cas9 for gene editing of WDR4 (human TRM82)

  • Apply lentiviral vectors for stable expression

  • Assess impact on translation fidelity using reporter constructs

  • Examine cell-specific expression patterns via immunofluorescence

• In vitro reconstitution:

  • Express and purify recombinant Trm8 and Trm82/WDR4 proteins

  • Perform enzymatic assays with synthetic or native tRNA substrates

  • Analyze complex formation using size exclusion chromatography

  • Conduct structural studies to elucidate interaction domains

How should researchers analyze transcriptomic data related to TRM82 function?

When analyzing transcriptomic data from TRM82 studies:

• Differential expression analysis:

  • Use appropriate statistical methods (DESeq2, edgeR) for RNA-Seq data

  • Apply multiple testing correction (FDR < 0.05)

  • Consider fold-change thresholds alongside statistical significance

• Functional enrichment analysis:

  • Perform Gene Ontology (GO) enrichment for biological processes, cellular components, and molecular functions

  • Conduct KEGG pathway analysis to identify affected metabolic and signaling pathways

  • Use gene set enrichment analysis (GSEA) for detecting subtle but coordinated changes

• Integration with other data types:

  • Correlate transcriptomic changes with metabolomic data

  • Compare with proteomics data to identify post-transcriptional regulation

  • Analyze tRNA modification profiles in parallel

• Visualization approaches:

  • Create heatmaps of differentially expressed genes

  • Use volcano plots to highlight significant changes

  • Develop pathway maps showing coordinated regulation of metabolic processes

Recent studies employing transcriptomic analysis of Trm8/Trm82 overexpression identified 66 differentially expressed genes compared to wild-type, with significant enrichment in metabolic processes .

What are common pitfalls in interpreting TRM82 antibody-based experimental results?

Researchers should be aware of these common interpretation pitfalls:

• Antibody cross-reactivity:

  • Some antibodies may detect both TRM82/WDR4 and structurally related proteins

  • Verify bands at the expected molecular weight (approximately 50-55 kDa)

  • Confirm specificity with appropriate controls

• Cell-type specific expression:

  • Expression levels vary across tissues and cell types

  • Normalize to appropriate housekeeping genes/proteins

  • Consider context-dependent function interpretation

• Post-translational modifications:

  • TRM82/WDR4 may exhibit post-translational modifications affecting mobility

  • Multiple bands may represent different isoforms or modified forms

  • Phosphorylation status may impact complex formation with TRM8

• Complex formation interpretation:

  • TRM82 functions in a complex with TRM8

  • Overexpression of TRM82 alone may not recapitulate physiological function

  • Consider co-immunoprecipitation to verify complex formation

• Species differences:

  • Functional conservation across species is high but not complete

  • Antibody reactivity may vary between species even with conserved epitopes

  • Interpret cross-species comparisons cautiously

How can machine learning approaches enhance TRM82-related antibody-antigen binding research?

Recent advances in machine learning offer promising approaches for antibody research:

• Library-on-library screening optimization:

  • Active learning strategies can improve experimental efficiency in antibody-antigen binding prediction

  • Begin with small labeled subsets of data and iteratively expand through targeted experiments

  • Reduce experimental costs by up to 35% when predicting antibody-antigen interactions

• Out-of-distribution prediction challenges:

  • Machine learning models face challenges when predicting interactions with antibodies and antigens not represented in training data

  • Novel active learning algorithms can speed up the learning process by 28 steps compared to random baselines

  • Apply simulation frameworks like Absolut! to evaluate performance before wet-lab implementation

• Application to TRM82 antibody development:

  • Predict optimal epitopes for generating specific antibodies

  • Enhance screening efficiency when developing new TRM82 antibodies

  • Identify potential cross-reactivity issues before experimental validation

How does TRM82's role in tRNA modification connect to broader cellular stress responses?

The tRNA modification function of the Trm8/Trm82 complex has implications for cellular stress response mechanisms. Researchers should consider:

• Translation regulation during stress:

  • Investigate how Trm8/Trm82-mediated m7G modification affects tRNA stability during various stress conditions

  • Examine the role of TRM82 in stress granule formation and composition

  • Assess how TRM82 deficiency impacts selective translation during stress

• Metabolic adaptation pathways:

  • Explore the connection between TRM82-mediated metabolic changes and stress adaptation

  • Investigate whether TRM82 overexpression confers resistance to specific stressors

  • Determine if TRM82-dependent pathways are activated during particular stress responses

• Experimental approaches:

  • Apply various stressors (oxidative, thermal, nutrient deprivation) to TRM82 knockout/overexpression models

  • Monitor tRNA modification patterns under stress conditions

  • Perform ribosome profiling to assess translation efficiency of specific transcripts

What potential exists for TRM82 research in therapeutic antibody development?

While the search results don't directly address therapeutic applications of TRM82, recent advances in antibody research provide relevant context:

• Dual-antibody therapeutic strategies:

  • Recent work with SARS-CoV-2 demonstrates how paired antibodies (one serving as an anchor, another inhibiting function) can overcome viral evolution challenges

  • Similar approaches could be applied to target protein complexes like Trm8/Trm82

  • Investigate whether targeting TRM82 in disease contexts where tRNA modification is dysregulated might have therapeutic potential

• Methodological considerations:

  • Apply active learning strategies to optimize antibody development

  • Consider library-on-library approaches to identify optimal binding pairs

  • Leverage machine learning to predict binding affinities and specificity

• Research directions:

  • Investigate TRM82 expression in disease contexts

  • Determine whether TRM82 inhibition could modulate specific metabolic pathways in disease

  • Explore the potential of TRM82 as a biomarker for cellular stress states

What are common troubleshooting strategies for unsuccessful Western blot detection of TRM82?

When troubleshooting Western blot issues with TRM82 antibodies:

• No signal detected:

  • Verify sample expression (check if your cell type/tissue expresses TRM82/WDR4)

  • Increase antibody concentration (try 1:250 - 1:500 dilution)

  • Extend primary antibody incubation time (try 48 hours at 4°C)

  • Use more sensitive detection methods (enhanced ECL reagents)

  • Verify transfer efficiency with reversible stain

• Multiple non-specific bands:

  • Increase blocking time/concentration (5% BSA or 5% milk for 2 hours)

  • Add 0.1-0.3% Tween-20 to antibody dilution buffer

  • Perform more stringent washes (increase wash time and number)

  • Try a different antibody targeting a different epitope

  • Reduce primary antibody concentration

• Inconsistent results:

  • Standardize protein extraction protocol

  • Use fresh lysates and avoid multiple freeze-thaw cycles

  • Standardize loading with reliable housekeeping proteins

  • Prepare fresh transfer buffers and blocking solutions

  • Use positive control lysates in each experiment

How can researchers optimize immunoprecipitation protocols for TRM82/Trm8 complex studies?

For optimal immunoprecipitation of the TRM82/Trm8 complex:

• Lysis conditions:

  • Use mild non-ionic detergents (0.5-1% NP-40 or Triton X-100)

  • Include protease and phosphatase inhibitors

  • Maintain low temperatures throughout (4°C)

  • Consider crosslinking for transient interactions

• Antibody selection:

  • Choose antibodies validated for immunoprecipitation applications

  • Consider using antibodies against both complex members for verification

  • Pre-clear lysates to reduce non-specific binding

• Co-immunoprecipitation strategy:

  • Use antibodies against both TRM82 and TRM8 in parallel experiments

  • Include RNase treatment controls to distinguish RNA-dependent interactions

  • Elute under native conditions if downstream functional assays are planned

• Verification approaches:

  • Confirm co-immunoprecipitation by Western blotting for both proteins

  • Use mass spectrometry to identify additional interaction partners

  • Include negative controls (IgG from same species) and positive controls

What considerations are important when designing qPCR experiments to study TRM82 expression?

For reliable qPCR analysis of TRM82 expression:

• Primer design:

  • Design primers spanning exon-exon junctions to avoid genomic DNA amplification

  • Ensure primer specificity through in silico analysis and melt curve verification

  • Optimize primer concentrations and annealing temperatures

  • Include all TRM82/WDR4 transcript variants of interest

• Reference gene selection:

  • Validate multiple reference genes for your specific experimental system

  • Assess reference gene stability across experimental conditions

  • Use geometric averaging of multiple reference genes for normalization

• Controls and validation:

  • Include no-template controls and RT-minus controls

  • Validate primer efficiency using standard curves (90-110% efficiency)

  • Perform biological and technical replicates (minimum triplicate)

  • Consider absolute quantification for comparing expression across tissues

• Data analysis:

  • Apply appropriate statistical methods for relative quantification

  • Use the 2^(-ΔΔCt) method for fold-change calculations with validated primers

  • Report both statistical significance and biological relevance of findings

  • Consider correlation with protein expression levels via Western blot